← Leaderboards
Scott Noblitt
Armis Biopharma, Inc.
$2,079,857
Attributed
$2,079,857
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $858.4K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,079,857 · 1
By mechanism
R44$2,079,857 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Nerve Agent”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,555,546
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,555,546
- James Dale Berry · Brigham And Women'S Hospital$9,815,535
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Thimmasettappa Thippeswamy · Iowa State University$6,425,429
Research focus
Nerve AgentTerrorismIncentivesMass CasualtyProgram DevelopmentSkinAntibioticsDecontaminantIn VivoLiquid SubstancePathogenAnimalsChemical Warfare AgentsSafetyEventExposure ToFda ApprovedFirst ResponderFormulationDecontaminationGrantHandChemical WarfareToxic Effect
Grant awards (5)
Development of a novel product for skin decontamination after exposure to chemical warfare agents$828,836
R44 · FY2023 · NS · contact PI
Development of a novel product for skin decontamination after exposure to chemical warfare agents$29,610
R44 · FY2023 · NS · contact PI
Development of a novel product for skin decontamination after exposure to chemical warfare agents$526,918
R44 · FY2022 · NS · contact PI
Development of a novel product for skin decontamination after exposure to chemical warfare agents$271,445
R44 · FY2021 · NS · contact PI
Development of a novel product for skin decontamination after exposure to chemical warfare agents$423,048
R44 · FY2020 · NS · contact PI